Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol

BACKGROUND: Mixed dyslipidemia [elevated non-high-density lipoprotein cholesterol (non-HDL-C) and triglycerides (TGs), and decreased HDL-C] is common in type 2 diabetes mellitus (T2DM) and is associated with increased cardiovascular risk. Non-HDL-C and apolipoprotein B (ApoB) are the preferred thera...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cardiovasc Diabetol
Autors principals: Colhoun, Helen M., Leiter, Lawrence A., Müller-Wieland, Dirk, Cariou, Bertrand, Ray, Kausik K., Tinahones, Francisco J., Domenger, Catherine, Letierce, Alexia, Israel, Marc, Samuel, Rita, Del Prato, Stefano
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007683/
https://ncbi.nlm.nih.gov/pubmed/32035487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-0991-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars